142 related articles for article (PubMed ID: 12636163)
1. The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance.
Singh M; Ugozzoli M; Briones M; Kazzaz J; Soenawan E; O'Hagan DT
Pharm Res; 2003 Feb; 20(2):247-51. PubMed ID: 12636163
[TBL] [Abstract][Full Text] [Related]
2. A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA.
Singh M; Fang JH; Kazzaz J; Ugozzoli M; Chesko J; Malyala P; Dhaliwal R; Wei R; Hora M; O'Hagan D
Int J Pharm; 2006 Dec; 327(1-2):1-5. PubMed ID: 16962267
[TBL] [Abstract][Full Text] [Related]
3. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
Denis-Mize KS; Dupuis M; MacKichan ML; Singh M; Doe B; O'Hagan D; Ulmer JB; Donnelly JJ; McDonald DM; Ott G
Gene Ther; 2000 Dec; 7(24):2105-12. PubMed ID: 11223992
[TBL] [Abstract][Full Text] [Related]
4. The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.
Briones M; Singh M; Ugozzoli M; Kazzaz J; Klakamp S; Ott G; O'Hagan D
Pharm Res; 2001 May; 18(5):709-12. PubMed ID: 11465430
[No Abstract] [Full Text] [Related]
5. Japanese encephalitis virus vaccine formulations using PLA lamellar and PLG microparticles.
Yeh MK; Coombes AG; Chen JL; Chiang CH
J Microencapsul; 2002; 19(5):671-82. PubMed ID: 12433308
[TBL] [Abstract][Full Text] [Related]
6. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
Kazzaz J; Singh M; Ugozzoli M; Chesko J; Soenawan E; O'Hagan DT
J Control Release; 2006 Feb; 110(3):566-73. PubMed ID: 16360956
[TBL] [Abstract][Full Text] [Related]
8. Charged polylactide co-glycolide microparticles as antigen delivery systems.
Singh M; Kazzaz J; Ugozzoli M; Chesko J; O'Hagan DT
Expert Opin Biol Ther; 2004 Apr; 4(4):483-91. PubMed ID: 15102598
[TBL] [Abstract][Full Text] [Related]
9. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles.
Denis-Mize KS; Dupuis M; Singh M; Woo C; Ugozzoli M; O'Hagan DT; Donnelly JJ; Ott G; McDonald DM
Cell Immunol; 2003 Sep; 225(1):12-20. PubMed ID: 14643300
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.
Desai MP; Labhasetwar V; Walter E; Levy RJ; Amidon GL
Pharm Res; 1997 Nov; 14(11):1568-73. PubMed ID: 9434276
[TBL] [Abstract][Full Text] [Related]
12. Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.
Vaishya RD; Mandal A; Patel S; Mitra AK
Int J Pharm; 2015 Dec; 496(2):676-88. PubMed ID: 26561725
[TBL] [Abstract][Full Text] [Related]
13. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS
Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098
[TBL] [Abstract][Full Text] [Related]
14. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
Delgado A; Lavelle EC; Hartshorne M; Davis SS
Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
[TBL] [Abstract][Full Text] [Related]
15. Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties.
del Barrio GG; Novo FJ; Irache JM
J Control Release; 2003 Jan; 86(1):123-30. PubMed ID: 12490378
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles.
Dunne M; Bibby DC; Jones JC; Cudmore S
J Control Release; 2003 Sep; 92(1-2):209-19. PubMed ID: 14499198
[TBL] [Abstract][Full Text] [Related]
17. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
18. Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.
Singh M; Ott G; Kazzaz J; Ugozzoli M; Briones M; Donnelly J; O'Hagan DT
Pharm Res; 2001 Oct; 18(10):1476-9. PubMed ID: 11697476
[No Abstract] [Full Text] [Related]
19. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
20. Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.
Mollenkopf HJ; Dietrich G; Fensterle J; Grode L; Diehl KD; Knapp B; Singh M; O'Hagan DT; Ulmer JB; Kaufmann SH
Vaccine; 2004 Jul; 22(21-22):2690-5. PubMed ID: 15309815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
